更正：抑郁症合并边缘型人格障碍--氯胺酮能否成为治疗催化剂？

IF 3.2 3区医学 Q2 PSYCHIATRY

Frontiers in Psychiatry Pub Date : 2024-10-28 eCollection Date: 2024-01-01 DOI:10.3389/fpsyt.2024.1507504

Magdalena Więdłocha, Piotr Marcinowicz, Jan Komarnicki, Małgorzata Tobiaszewska, Weronika Dębowska, Marta Dębowska, Agata Szulc

引用次数: 0

摘要

[此处更正了文章 DOI：10.3389/fpsyt.2024.1398859]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Corrigendum: Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?

[This corrects the article DOI: 10.3389/fpsyt.2024.1398859.].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Frontiers in Psychiatry Medicine-Psychiatry and Mental Health

CiteScore

6.20

自引率

8.50%

发文量

2813

审稿时长

14 weeks

期刊介绍： Frontiers in Psychiatry publishes rigorously peer-reviewed research across a wide spectrum of translational, basic and clinical research. Field Chief Editor Stefan Borgwardt at the University of Basel is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. The journal''s mission is to use translational approaches to improve therapeutic options for mental illness and consequently to improve patient treatment outcomes.